发明名称 |
Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
摘要 |
This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival. |
申请公布号 |
US8796422(B2) |
申请公布日期 |
2014.08.05 |
申请号 |
US201313962110 |
申请日期 |
2013.08.08 |
申请人 |
Morehouse School of Medicine |
发明人 |
Lillard, Jr. James W. |
分类号 |
C07K1/00;C12P21/08;C07K16/28;A61K38/00 |
主分类号 |
C07K1/00 |
代理机构 |
Andrews Kurth LLP |
代理人 |
Wang Ping;Andrews Kurth LLP |
主权项 |
1. An isolated chemokine-immunoglobulin fusion polypeptide, comprising:
a CCL2 moiety and an immunoglobulin moiety comprising a constant region of a human immunoglobulin wherein when the chemokine-immunoglobulin fusion polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:54. |
地址 |
Atlanta GA US |